Wordt geladen...
Clinical Efficacy Evaluation of Sirolimus in Congenital Hyperinsulinism
BACKGROUND: Congenital hyperinsulinism (CHI) is a rare and life-threatening genetic disorder. Sirolimus as a mammalian target of rapamycin inhibitor may be helpful in patients with CHI who do not respond well to other treatments including diazoxide and octreotide. However, the safety and efficacy of...
Bewaard in:
| Gepubliceerd in: | Int J Endocrinol |
|---|---|
| Hoofdauteurs: | , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Hindawi
2020
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7396056/ https://ncbi.nlm.nih.gov/pubmed/32774365 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2020/7250406 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|